Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Colchicine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.9% during the forecast period.
This report presents the market size and development trends by detailing the Colchicine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Colchicine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Colchicine industry and will help you to build a panoramic view of the industrial development.
Colchicine Market, By Type:
Tablet
Oral Solution
Colchicine Market, By Application:
Acute Gout
Chronic Gout
Other Conditions
Some of the leading players are as follows:
Xishuangbanna Pharmaceutical
Yunnan Plant Medicine
Odan Laboratories
Tonghua Limin
Beijing Jialin Pharmaceutical
Wockhardt
Rhea Pharmaceutical
Hikma
West-Ward
Guangdong Pedi
Medinova
Cipla
Kunming Pharmaceutical
Excellium Pharmaceutical
Yunnan Shan State
Takeda Pharmaceuticals
Prasco
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Colchicine Market: Technology Type Analysis
-
4.1 Colchicine Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Colchicine Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Tablet
4.3.2 Oral Solution
5 Colchicine Market: Product Analysis
-
5.1 Colchicine Product Market Share Analysis, 2018 & 2026
-
5.2 Colchicine Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Colchicine Market: Application Analysis
-
6.1 Colchicine Application Market Share Analysis, 2018 & 2026
-
6.2 Colchicine Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Acute Gout
6.3.2 Chronic Gout
6.3.3 Other Conditions
7 Colchicine Market: Regional Analysis
-
7.1 Colchicine Regional Market Share Analysis, 2018 & 2026
-
7.2 Colchicine Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Xishuangbanna Pharmaceutical
9.1.1 Xishuangbanna Pharmaceutical Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Yunnan Plant Medicine
9.2.1 Yunnan Plant Medicine Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Odan Laboratories
9.3.1 Odan Laboratories Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Tonghua Limin
9.4.1 Tonghua Limin Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Beijing Jialin Pharmaceutical
9.5.1 Beijing Jialin Pharmaceutical Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Wockhardt
9.6.1 Wockhardt Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Rhea Pharmaceutical
9.7.1 Rhea Pharmaceutical Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Hikma
9.8.1 Hikma Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 West-Ward
9.9.1 West-Ward Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Guangdong Pedi
9.10.1 Guangdong Pedi Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Medinova
9.11.1 Medinova Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Cipla
9.12.1 Cipla Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Kunming Pharmaceutical
9.13.1 Kunming Pharmaceutical Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Excellium Pharmaceutical
9.14.1 Excellium Pharmaceutical Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 Yunnan Shan State
9.15.1 Yunnan Shan State Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 Takeda Pharmaceuticals
9.16.1 Takeda Pharmaceuticals Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
9.17 Prasco
9.17.1 Prasco Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.17.5 SWOT analysis
The List of Tables and Figures (Totals 68 Figures and 132 Tables)
Figure Tablet Colchicine market, 2015 - 2026 (USD Million)
Figure Oral Solution Colchicine market, 2015 - 2026 (USD Million)
Figure Acute Gout market, 2015 - 2026 (USD Million)
Figure Chronic Gout market, 2015 - 2026 (USD Million)
Figure Other Conditions market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Colchicine market, by country, 2015 - 2026 (USD Million)
-
Table North America Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table North America Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table North America Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table Canada Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table Canada Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table Europe Colchicine market, by country, 2015 - 2026 (USD Million)
-
Table Europe Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table Europe Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table Europe Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table Germany Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table Germany Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table France Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table France Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table Italy Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table Italy Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table Spain Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table Spain Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Colchicine market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table China Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table China Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table Japan Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table Japan Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table India Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table India Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Colchicine market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table MEA Colchicine market, by country, 2015 - 2026 (USD Million)
-
Table MEA Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table MEA Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table MEA Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Colchicine market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Colchicine market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Colchicine market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Xishuangbanna Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Yunnan Plant Medicine Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Odan Laboratories Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Tonghua Limin Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Beijing Jialin Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Wockhardt Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Rhea Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hikma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table West-Ward Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Guangdong Pedi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Medinova Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cipla Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Kunming Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Excellium Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Yunnan Shan State Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Takeda Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Prasco Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
